Stryker Cash Conversion Cycle from 2010 to 2024

SYK Stock  USD 364.60  7.46  2.09%   
Stryker Cash Conversion Cycle yearly trend continues to be quite stable with very little volatility. The value of Cash Conversion Cycle is projected to decrease to 159.14. From the period between 2010 and 2024, Stryker, Cash Conversion Cycle regression line of its data series had standard deviation of  27.93 and standard deviation of  27.93. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
231.07244294
Current Value
159.14
Quarterly Volatility
27.93090986
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 373.8 M or Total Revenue of 21.5 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0054 or PTB Ratio of 6.37. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
  
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

Latest Stryker's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Stryker over the last few years. It is Stryker's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Very volatile
   Cash Conversion Cycle   
       Timeline  

Stryker Cash Conversion Cycle Regression Statistics

Arithmetic Mean212.63
Geometric Mean210.89
Coefficient Of Variation13.14
Mean Deviation23.46
Median207.69
Standard Deviation27.93
Sample Variance780.14
Range95.2196
R-Value0.09
Mean Square Error833.15
R-Squared0.01
Significance0.75
Slope0.57
Total Sum of Squares10,922

Stryker Cash Conversion Cycle History

2024 159.14
2023 231.07
2022 207.69
2021 194.36
2020 253.75
2019 254.36
2018 243.32

About Stryker Financial Statements

Stryker investors utilize fundamental indicators, such as Cash Conversion Cycle, to predict how Stryker Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Conversion Cycle 231.07  159.14 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.2
Dividend Share
3.2
Earnings Share
9.33
Revenue Per Share
57.728
Quarterly Revenue Growth
0.119
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.